Overview
David Maas is a Palliative Medicine provider in San Jose, California. His top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
751 S Bascom Ave, Santa Clava Vly Med, San Jose, CA 95128
Stanford Health Care
Kavitha Ramchandran is an Oncologist and a Palliative Medicine provider in Stanford, California. Dr. Ramchandran is highly rated in 13 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Pleuropulmonary Blastoma.
Monterey Bay Oncology A Medical Corporation
John Hausdorff is a Palliative Medicine specialist and an Oncologist in Monterey, California. Dr. Hausdorff is highly rated in 30 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Paget Disease of the Breast.
Lilly Chen is a Palliative Medicine provider in Martinez, California. Dr. Chen is highly rated in 2 conditions, according to our data. Her top areas of expertise are Chronic Pain and Deep Brain Stimulation.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer